by TractManager | Dec 21, 2021 | Emerging Technology Report
Vyvgart (efgartigimod alfa-fcab) is a first-in-class intravenously administered neonatal Fc receptor blocker indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.If you have a...
by TractManager | Dec 16, 2021 | News
Getinge/Datascope/Maquet is recalling Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic Balloon Pump (IABP) due to complaints of fluid leaks. The CardioSave Hybrid/Rescue IABPs are cardiac assist devices used with patients undergoing cardiac and non-cardiac...
by TractManager | Dec 16, 2021 | Health Technology Assessment
Focus of the Report: This health technology assessment focuses on the use of the BostonSight prosthetic replacement of the ocular surface ecosystem (PROSE) treatment for primary or secondary dry eye disease (DED) in adults and pediatric patients.Technology...
by TractManager | Dec 15, 2021 | Emerging Technology Report
Optilume is drug-coated balloon indicated to treat patients with obstructive urinary symptoms associated with anterior urethral stricture. It is designed to be used in adult males with urethral strictures ≤ 3 cm in length.If you have a Hayes login, click here to view...
by TractManager | Dec 10, 2021 | Evolving Evidence Review
If you have a Hayes login, click here to view the full report on the Knowledge Center.
Recent Comments